These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2831638)

  • 21. The stimulatory effects of cationic amphiphilic drugs on human platelets treated with thrombin.
    Tharmapathy P; Fukami MH; Holmsen H
    Biochem Pharmacol; 2000 Nov; 60(9):1267-77. PubMed ID: 11008120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin increases cytosolic free calcium concentration and thrombin induced changes in cytosolic free calcium in platelets from spontaneously hypertensive rats.
    Tepel M; Wischniowski H; Zidek W
    Biochem Biophys Res Commun; 1991 Jun; 177(3):991-7. PubMed ID: 2059226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human platelet activation by bacterial phospholipase C: mechanism of inhibition by flurazepam.
    Anwer K; Wallace D; Romstedt K; Huzoor-Akbar
    Thromb Res; 1988 Jan; 49(2):225-39. PubMed ID: 2896397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced functions of intracellular Ca2+ in aggregation, secretion and protein phosphorylation of permeabilized platelets from stroke-prone spontaneously hypertensive rats.
    Ikeda M; Onda T; Tomita I; Tomita T
    Thromb Res; 1992 Sep; 67(6):655-63. PubMed ID: 1440531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet calcium handling in spontaneously hypertensive rats and in three strains of normotensive rats.
    Ishida-Kainouchi M; Matsuura H; Ishida T; Kajiyama G; Oshima T
    J Hypertens; 1993 May; 11(5):509-14. PubMed ID: 8390522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDM.
    Bastyr EJ; Kadrofske MM; Dershimer RC; Vinik AI
    Diabetes; 1989 Sep; 38(9):1097-102. PubMed ID: 2548908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defects of thrombin-induced protein phosphorylation in platelets from stroke-prone spontaneously hypertensive rats.
    Umegaki K; Ikeda M; Nakamura K; Tomita T
    FEBS Lett; 1986 Feb; 196(1):139-44. PubMed ID: 3943626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets.
    Vickers JD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered platelet phosphatidylinositol metabolism in essential hypertension.
    Dimitrov D; Resink TJ; Müller FB; Bühler FR
    J Hypertens Suppl; 1986 Dec; 4(6):S346-8. PubMed ID: 3039092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective calcium transport in platelets from stroke-prone spontaneously hypertensive rats.
    Umegaki K; Ikeda M; Tomita T
    Thromb Res; 1986 Feb; 41(3):415-23. PubMed ID: 3705015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal calcium handling by platelets of spontaneously hypertensive rats.
    Oshima T; Young EW; Bukoski RD; McCarron DA
    Hypertension; 1990 Jun; 15(6 Pt 1):606-11. PubMed ID: 2347623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of norepinephrine-induced tonic contraction and phosphoinositide turnover in arteries of spontaneously hypertensive rats. A possible role for protein kinase C.
    Ek TP; Campbell MD; Deth RC; Gowraganahalli J
    Am J Hypertens; 1989 Jan; 2(1):40-5. PubMed ID: 2536545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal platelet and lymphocyte calcium handling in prehypertensive rats.
    Oshima T; Young EW; McCarron DA
    Hypertension; 1991 Jul; 18(1):111-5. PubMed ID: 1860705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired phospholipase C activity is involved in the hyperreactivity of platelets in primary hypertension.
    Koutouzov S; Limon I; Meyer P; Marche P
    J Hypertens Suppl; 1988 Dec; 6(4):S372-4. PubMed ID: 3241220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats.
    Gomez E; Schwendemann C; Roger S; Simonet S; Paysant J; Courchay C; Verbeuren TJ; Félétou M
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2198-211. PubMed ID: 18820028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism.
    Steen VM; Tysnes OB; Holmsen H
    Biochem J; 1988 Jul; 253(2):581-6. PubMed ID: 2845924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet phosphoinositide turnover in streptozotocin-induced diabetes.
    Jethmalani SM; Dang AQ; Faas FH
    Prostaglandins Leukot Essent Fatty Acids; 1994 Jun; 50(6):339-46. PubMed ID: 7938087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of phosphoinositides in human platelets.
    Suga K; Kambayashi J; Kawasaki T; Sakon M; Mori T
    Thromb Res; 1986 Oct; 44(2):155-63. PubMed ID: 3024354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The aggregation of human platelet induced by ganodermic acid S.
    Wang CN; Chen JC; Shiao MS; Wang CT
    Biochim Biophys Acta; 1989 Nov; 986(1):151-60. PubMed ID: 2819092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The differences in Ca(2+)-sensitivity of protein kinase C in platelets from Wistar Kyoto rat and stroke-prone spontaneously hypertensive rat.
    Ikeda M; Onda T; Tomita I; Tomita T
    Thromb Res; 1996 Jun; 82(5):417-27. PubMed ID: 8771702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.